These findings, from a broad international cohort including low-, middle-, and high-income countries, support the incorporation of 68Ga-PSMA-11 PET/CT into standard staging for high-risk PCa, particularly in patients for whom radical prostatectomy is being considered. Here, FOLH1 is linked to posterior cortical atrophy.